Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 3, 2012, Pages 251-256

  Mohammadi, Afshin ^a   Bazazi, Ali ^a   Maleki Miyandoab, Tooraj ^a   Ghasemi rad, Mohammad ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Fatty liver; Ultrasonography

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RISK FACTOR;

EID: 84864314976     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Balmer ML, Dufour JF. Non-alcoholic steatohepatitis -from NAFLD to MAFLD. Ther Umsch 2011; 68: 183-188.
2. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, Chim AM, Yu CM, Yu J, Chan FK, Sung JJ, Chan HL. Coronary artery disease and cardiovascular outcomes in patients with nonalcoholic fatty liver disease. Gut 2011; 60: 1721-1727.
3. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161.
4. Mohammadi A, Ghasemi-rad M, Zahedi H, Toldi G, Alinia T. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Med Ultrason 2011; 13: 200-206.
5. Tarquini R, Lazzeri C, Boddi M, Marra F, Abbate R, Gensini GF. Non-alcoholic fatty liver disease: a new challenge for cardiologists. G Ital Cardiol (Rome) 2010; 11: 660-669.
6. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in nonalcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008; 51: 1947-1953.
7. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-2283.
8. Liu LR, Fu JF, Liang L, Huang K.Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity. Zhongguo Dang Dai Er Ke Za Zhi 2010; 12: 547-550.
9. Targher G, Day CP, Bonora E. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. N Engl J Med 2010; 363: 1341-1350.
10. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-787.
11. Szollar L. Fatty liver and global cardiometabolic risk. Orv Hetil 2010; 15: 1946-1950.
12. Pascale A, Pais R, Ratziu V. An overview of nonalcoholic steatohepatitis:Past. Present and future direction. J Gastrointestin Liver Dis 2010; 19: 415-423.
13. Duvnjak M, Lerotic I, Barsic N, Tomasic V, Virovic Jukic L, Velagic V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007; 13: 4539-4550.
14. Schindler TH, Nitzsche EU, Olschewski M, Magosaki N, Mix M, Prior JO, Facta AD, Solzbach U, Just H, Schelbert HR. Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors. Circulation 2004; 110: 1069-1075.
15. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, Levy Y, Brook GJ, Aronson D. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005; 25: 193-197.
16. Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2005; 21: 702-707.
17. Scott Rector R, Thyfault JP, Wei Y, A Ibdah J. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol 2008; 14: 185-192.
18. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab 2008; 93: S74-S80.
19. de Alwis NMW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48: S104-S112.
20. Nseir W, Shalata A, Marmor A, Assy N. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease. Dig Dis Sci 2012; 57: 1109.
21. del Sol IA, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: relation to incident myocardial infarction. The Rotterdam study. Eur Heart J 2002; 23: 934-940.
22. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004; 90: 1286-1290.
23. Mohammadi A, Bazazi A, Ghasemi-rad M. Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease. Int J Gen Med 2011: 4: 1-6.
24. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
25. Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V. Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol 2009; 15: 4770-4774.
26. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, Schminke U, Kessler C, John U. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005; 11: 1848-1853.
27. Angulo P. Nonalcoholic fatty liver disease. N Eng J Med 2002; 36: 1221-1231.
28. Mohammadi A, Sedani HH, Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag 2011; 7: 661-665.